Cargando…
Opportunities and Limitations of Modelling Alzheimer’s Disease with Induced Pluripotent Stem Cells
Reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) has opened the way for patient-specific disease modelling. Following their differentiation into neuronal cell types, iPSC have enabled the investigation of human neurodegenerative diseases, such as Alzheimer’s disease (AD). W...
Autores principales: | Ovchinnikov, Dmitry A., Wolvetang, Ernst J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470188/ https://www.ncbi.nlm.nih.gov/pubmed/26237606 http://dx.doi.org/10.3390/jcm3041357 |
Ejemplares similares
-
Modelling ischemia-reperfusion injury (IRI) in vitro using metabolically matured induced pluripotent stem cell-derived cardiomyocytes
por: Hidalgo, Alejandro, et al.
Publicado: (2018) -
Inhibition of DYRK1A disrupts neural lineage specificationin human pluripotent stem cells
por: Bellmaine, Stephanie F, et al.
Publicado: (2017) -
Leucine-rich repeat-containing G protein-coupled receptor 5 marks different cancer stem cell compartments in human Caco-2 and LoVo colon cancer lines
por: Alharbi, Samah Abdulaali, et al.
Publicado: (2021) -
Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease
por: Wu, Yi-Ying, et al.
Publicado: (2019) -
Human pluripotent stem cell (hPSC) and organoid models of autism: opportunities and limitations
por: Kilpatrick, Savannah, et al.
Publicado: (2023)